Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Karlsson

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to VMarco Colleoni, Zhuoxin Sun, Karen N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2023
Reply to V. Nardone et alMartin Sjöström, Anthony Fyles, Fei-Fei Liu, et al.
Cell Death Discovery|January 29, 2024
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancerPeter Larsson, Daniella Pettersson, Maxim Olsson, et al.
The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA studyMichael Andersson, Elisabeth Lidbrink, Karsten Bjerre, et al.
Journal of Ovarian Research|May 19, 2025
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinomaHugo Swenson, Ella Ittner, Lucas Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic TherapyMartin Sjöström, S Laura Chang, Nick Fishbane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT TrialAxel Stenmark Tullberg, Martin Sjöström, Emma Niméus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2011
Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET studyAkihiro Takano, Balázs Gulyás, Andrea Varrone, et al.
Journal of the National Cancer Institute|May 7, 2025
Response to Li, Liu, Duan et alPer Karlsson, Fyles Anthony, Bradley Arrick, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to VMarco Colleoni, Zhuoxin Sun, Karen N Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2023
Reply to V. Nardone et alMartin Sjöström, Anthony Fyles, Fei-Fei Liu, et al.
Cell Death Discovery|January 29, 2024
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancerPeter Larsson, Daniella Pettersson, Maxim Olsson, et al.
The International Journal of Neuropsychopharmacology|August 22, 2007
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brainAnna-Lena Nordstrom, Mattias Mansson, Hristina Jovanovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA studyMichael Andersson, Elisabeth Lidbrink, Karsten Bjerre, et al.
Journal of Ovarian Research|May 19, 2025
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinomaHugo Swenson, Ella Ittner, Lucas Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic TherapyMartin Sjöström, S Laura Chang, Nick Fishbane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT TrialAxel Stenmark Tullberg, Martin Sjöström, Emma Niméus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2011
Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET studyAkihiro Takano, Balázs Gulyás, Andrea Varrone, et al.
Journal of the National Cancer Institute|May 7, 2025
Response to Li, Liu, Duan et alPer Karlsson, Fyles Anthony, Bradley Arrick, et al.
Pageof 18